Flagship Pioneering is a Cambridge, Massachusetts-based venture creation firm that conceives, creates, resources, and grows first-in-category companies across health technology, biotechnology, medicine, engineering, energy, and related fields. The organization aims to transform human health and sustainability by turning seemingly unreasonable ideas into transformational ventures through an evolutionary, science-driven approach. It combines inventive capacity, entrepreneurial leadership, and capital management within a single enterprise to systematically build new companies that pursue breakthrough advances in biology, engineering, and medicine. Since its founding in 2000, Flagship Pioneering has developed and nurtured a portfolio of ventures by integrating scientific discovery with disciplined entrepreneurship, seeking to accelerate innovations from concept to market.
Senior Vice President and Partner, Corporate Communications and Social Impact
Ben Kompa
Senior Associate
Brad Kubick
Senior Associate
John Lepore
CEO-Partner
Justine Levin-Allerhand Ph.D
Senior Partner
Scott Lipnick
Senior Principal
Heng Lu
Investor
Amy Lyons
Senior Director of Communications
John Mendlein
Partner
Diego Miralles
Partner
Armen Mkrtchyan
Origination Partner
Ayse Muñiz
Senior Associate
Michael Nally
Partner
Charlotte Nicod
Senior Associate
Torben Straight Nissen
Partner
Yajie Niu
Principal
Tuyen Ong
Partner
Guillaume Pfefer
Partner
Stacie Rader
Partner
Pranay Randad
Senior Associate
Ranjit Randhawa
Senior Principal
Robert Rosiello
Partner
Jacob Rubens
Principal
Christian Schade
Growth Partner
Michael Severino MD
CEO-Partner
Alexandra Sneider
Senior Associate
Nathan Stebbins
Principal
Hok Hei Tam
Senior Associate
Leda Trivinos
Partner
Jeffrey Tsao
Senior Operating Principal
Dmytro Ustianenko
Associate
Erica Weinstein
Principal
Geoff Whitehead Ph.D
Principal
Harry Wilcox
General Partner
Sabrina Yang
Senior Associate
Marie Yurkovich
Senior Associate
Sophie de Boer
Senior Associate
Katharine von Herrmann
Principal
Geoffrey von Maltzahn
General Partner
Past deals in Series G
Inari
Series G in 2025
Inari is a biotechnology company focused on revolutionizing agriculture and its societal and environmental impact. The company utilizes advanced technologies, including predictive design and multiplex gene editing, to maximize the potential of seeds. Its unique SEEDesign platform distinguishes Inari by enabling the enhancement of various crops across different geographies, facilitating the development of innovative agricultural products. By embracing diversity, Inari fosters innovation and aims to contribute to the creation of a new food system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.